Genetic Etiology of Isolated Low HDL Syndrome: Incidence and Heterogeneity of Efflux Defects

Objective—We have used a multitiered approach to identify genetic and cellular contributors to high-density lipoprotein (HDL) deficiency in 124 human subjects. Methods and Results—We resequenced 4 candidate genes for HDL regulation and identified several functional nonsynonymous mutations including 2 in apolipoprotein A-I (APOA1), 4 in lecithin:cholesterol acyltransferase (LCAT), 1 in phospholipid transfer protein (PLTP), and 7 in the ATP-binding cassette transporter ABCA1, leaving 88% (110/124) of HDL deficient subjects without a genetic diagnosis. Cholesterol efflux assays performed using cholesterol-loaded monocyte-derived macrophages from the 124 low HDL subjects and 48 control subjects revealed that 33% (41/124) of low HDL subjects had low efflux, despite the fact that the majority of these subjects (34/41) were not carriers of dysfunctional ABCA1 alleles. In contrast, only 2% of control subjects presented with low efflux (1/48). In 3 families without ABCA1 mutations, efflux defects were found to cosegregate with low HDL. Conclusions—Efflux defects are frequent in low HDL syndromes, but the majority of HDL deficient subjects with cellular cholesterol efflux defects do not harbor ABCA1 mutations, suggesting that novel pathways contribute to this phenotype.

[1]  R. S. Kiss,et al.  Cathepsin D, a Lysosomal Protease, Regulates ABCA1-mediated Lipid Efflux* , 2006, Journal of Biological Chemistry.

[2]  David W. Williamson,et al.  Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks. , 2005, Atherosclerosis.

[3]  M. Freeman,et al.  ATP-binding Cassette Transporter A1 Contains a Novel C-terminal VFVNFA Motif That Is Required for Its Cholesterol Efflux and ApoA-I Binding Activities* , 2004, Journal of Biological Chemistry.

[4]  Jonathan C. Cohen,et al.  Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol , 2004, Science.

[5]  J. Marsh.  Lipoprotein metabolism in obesity and diabetes: insights from stable isotope kinetic studies in humans. , 2003, Nutrition reviews.

[6]  M. Taskinen,et al.  Determinants of low HDL levels in familial combined hyperlipidemia Published, JLR Papers in Press, June 1, 2003. DOI 10.1194/jlr.M300069-JLR200 , 2003, Journal of Lipid Research.

[7]  D. Rader,et al.  Expression of Human Hepatic Lipase in the Rabbit Model Preferentially Enhances the Clearance of Triglyceride‐Enriched Versus Native High‐Density Lipoprotein Apolipoprotein A‐I , 2003, Circulation.

[8]  J. Genest,et al.  Cellular Phospholipid and Cholesterol Efflux in High-Density Lipoprotein Deficiency , 2003, Circulation.

[9]  K. Zeller,et al.  ABCA1Alabama: a novel variant associated with HDL deficiency and premature coronary artery disease , 2002 .

[10]  D. Gómez-Coronado,et al.  Analysis of apolipoprotein A-I, lecithin:cholesterol acyltransferase and glucocerebrosidase genes in hypoalphalipoproteinemia. , 2002, Atherosclerosis.

[11]  M. Hayden,et al.  Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency. , 2002, Biochemical and biophysical research communications.

[12]  D. Sviridov,et al.  Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein. , 2001, Atherosclerosis.

[13]  A. Sekine,et al.  High-density single-nucleotide polymorphism (SNP) map of the 150-kb region corresponding to the human ATP-binding cassette transporter A1 (ABCA1) gene , 2001, Journal of Human Genetics.

[14]  R. Hegele,et al.  Lecithin:cholesterol acyl transferase G30S: association with atherosclerosis, hypoalphalipoproteinemia and reduced in vivo enzyme activity. , 2001, Clinical biochemistry.

[15]  J. Brady,et al.  Analysis of Glomerulosclerosis and Atherosclerosis in Lecithin Cholesterol Acyltransferase-deficient Mice* , 2001, The Journal of Biological Chemistry.

[16]  T. Hudson,et al.  Common Genetic Variation in ABCA1 Is Associated With Altered Lipoprotein Levels and a Modified Risk for Coronary Artery Disease , 2001, Circulation.

[17]  M. Hayden,et al.  Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. , 2000, The Journal of clinical investigation.

[18]  J. Genest,et al.  Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations. , 2000, Atherosclerosis.

[19]  S. Harvey,et al.  Detailed molecular model of apolipoprotein A-I on the surface of high-density lipoproteins and its functional implications. , 2000, Trends in cardiovascular medicine.

[20]  L. M. Thurston,et al.  Novel mutations in the gene encoding ATP-binding cassette 1 in four tangier disease kindreds. , 2000, Journal of lipid research.

[21]  A. Tall,et al.  Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. , 2000, Journal of lipid research.

[22]  R. Asmis,et al.  Large variations in human foam cell formation in individuals: a fully autologous in vitro assay based on the quantitative analysis of cellular neutral lipids. , 2000, Atherosclerosis.

[23]  P. Denéfle,et al.  Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Sensen,et al.  Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux , 1999, The Lancet.

[25]  T. Langmann,et al.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.

[26]  C. Sensen,et al.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.

[27]  J. Piette,et al.  Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.

[28]  M. Jauhiainen,et al.  Structure and phospholipid transfer activity of human PLTP: analysis by molecular modeling and site-directed mutagenesis. , 1999, Journal of lipid research.

[29]  J. Little,et al.  Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group. , 1999, Canadian Journal of Cardiology.

[30]  A. Tall,et al.  Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. , 1999, The Journal of clinical investigation.

[31]  A. von Eckardstein,et al.  Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers. , 1999, Journal of lipid research.

[32]  T. Arinami,et al.  Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-I gene in the population: a population-based survey. , 1999, Human molecular genetics.

[33]  G. Luc,et al.  Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. , 1998, Circulation.

[34]  M. Jauhiainen,et al.  Biosynthesis and secretion of human plasma phospholipid transfer protein. , 1998, Journal of lipid research.

[35]  M. Tremblay,et al.  Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[36]  J. Virtamo,et al.  Molecular Genetic Study of Finns With Hypoalphalipoproteinemia and Hyperalphalipoproteinemia A Novel Gly230Arg Mutation (LCATFin) of Lecithin:Cholesterol Acyltransferase (LCAT) Accounts for 5% of Cases With Very Low Serum HDL Cholesterol Levels , 1998 .

[37]  M. Freeman,et al.  Decreased cholesterol efflux from fibroblasts of a patient without Tangier disease, but with markedly reduced high density lipoprotein cholesterol levels. , 1998, The Journal of clinical endocrinology and metabolism.

[38]  A. von Eckardstein,et al.  A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma. , 1997, Journal of lipid research.

[39]  G. Luc,et al.  Fish-eye disease: structural and in vivo metabolic abnormalities of high-density lipoproteins. , 1997, Metabolism: clinical and experimental.

[40]  G. Assmann,et al.  A unique genetic and biochemical presentation of fish-eye disease. , 1995, The Journal of clinical investigation.

[41]  T. Yanase,et al.  Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344-->Ser). , 1995, Journal of lipid research.

[42]  K. Zeller,et al.  ABCA1(Alabama): a novel variant associated with HDL deficiency and premature coronary artery disease. , 2002, Atherosclerosis.

[43]  J. Genest,et al.  Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[44]  護山 健悟.  Two novel point mutations in the lecithin : Cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency : LCAT (G[873] deletion) and LCAT (Gly[344]→Ser) , 1995 .

[45]  C. Eng,et al.  Genetic Variation in PLTP Modulates Lipoprotein Profiles in Hyperalphalipoproteinemia , 2022 .